Radiation-hardened Electronics Market Size From 2023 to 2028 and Unlimited Opportunities for New Companies

According to the latest report by IMARC Group, titled “Radiation-Hardened Electronics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.’ the global radiation-hardened electronics market size reached US$ 1.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 1.6 Billion by 2028, exhibiting a growth rate (CAGR) of 2.9% during 2023-2028.

Radiation-hardened electronics represent a range of components, sensors, and single-board computer CPUs, primarily utilized for high-altitude applications. They are designed using several types of materials, including silicon, silicon carbide, gallium nitride, etc. Radiation-hardened electronics are mostly integrated into aircraft, satellites, and nuclear power plants in the form of microprocessors, switching regulators, and power supply devices. They are resistant to the damages caused by ionizing radiations, gamma radiations, and neutron radiations emitted by nuclear reactors and are less susceptible to the impacts of extreme temperatures. As a result, radiation-hardened electronics find extensive applications across various sectors, such as aviation, space, military and defense, etc.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Request a Free PDF Sample of the Report: https://www.imarcgroup.com/radiation-hardened-electronics-market/requestsample

Radiation-Hardened Electronics Market Trends:

The elevating number of space missions and exploratory activities are primarily driving the radiation-hardened electronics market. Besides this, the escalating need for communication satellites for intelligence, surveillance, and reconnaissance (ISR) operations is acting as another significant growth-inducing factor. Moreover, the increasing product usage in the manufacturing of power management instruments, diodes, transistors, and metal-oxide-semiconductor field-effect transistors (MOSFET) for numerous defense and military applications is further augmenting the market growth. Additionally, the development of highly reliable integrated circuits and the introduction of improved field-programmable gate array (FPGA) technology are anticipated to propel the radiation-hardened electronics market in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global radiation-hardened electronics market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product type, material type, technique, component type and application.

Competitive Landscape:

  • Analog Devices Inc
  • BAE Systems plc
  • Cobham Plc (Advent International)
  • Data Device Corporation (Transdigm Group Incorporated)
  • Honeywell International Inc
  • Microchip Technology Inc
  • STMicroelectronics
  • Texas Instruments Incorporated
  • The Boeing Company
  • Xilinx Inc., etc.

Breakup by Product Type: 

  • Custom Made
  • Commercial-Off-the-Shelf

Breakup by Material Type:

  • Silicon
  • Silicon Carbide
  • Gallium Nitride
  • Others

Breakup by Technique:

  • Radiation Hardening by Design (RHBD)
  • Radiation Hardening by Process (RHBP)
  • Radiation Hardening by Software (RHBS)

Breakup by Component Type:

  • Power Management
  • Application Specific Integrated Circuit
  • Logic
  • Memory
  • Field-Programmable Gate Array
  • Others

Breakup by Application:

  • Space Satellites
  • Commercial Satellites
  • Military
  • Aerospace and Defense
  • Nuclear Power Plants
  • Others

Breakup by Region:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • Middle East and Africa

Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=2172&flag=C

Key Highlights of the Report:                                                           

  • Market Performance (2017-2022)
  • Market Outlook (2023-2028)
  • Market Trends
  • Market Drivers and Success Factors
  • Impact of COVID-19
  • Value Chain Analysis
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:                                                                     

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group

30 N Gould St Ste R

Sheridan, WY 82801 USA – Wyoming

Email: Sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

Americas: - +1 631 791 1145 | Africa and Europe: - +44-702-409-7331 | Asia: +91-120-433-0800

 

Comments

Post a Comment

Popular posts from this blog

Outsourcing in Banking: Enhancing Efficiency and Addressing Risks

Image
Outsourcing in the banking sector has become a crucial strategy for streamlining products and services, optimizing resource management, reducing costs, and ultimately delivering greater value to customers. As financial institutions navigate a complex regulatory landscape, they are increasingly focusing on their core activities and looking for ways to enhance operational efficiency. The Need for Cost Optimization Banks face various challenges, including capital requirements, financial reporting, and corporate governance standards. Many institutions have shifted their attention from global capital markets to concentrate on their fundamental banking operations. This shift is essential not only for compliance but also for maintaining competitiveness in a market where operating costs significantly impact the pricing of financial products. To remain competitive, banks must find ways to lower their operational costs without compromising service quality. This is where outsourcing comes into pl...
Read more

North America Frozen Seafood Market: Industry Overview, Growth, Trends, Opportunities and Forecast Till 2026

Image
 According to IMARC Group’s latest report, titled “ North America Frozen Seafood Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026 ”, the North America frozen seafood market reached a value of US$ 13.4 Billion in 2020. Frozen seafood products are preserved for inhibiting the growth of bacteria in order to increase their shelf life, taste, and nutritional value. The seafood freezing technique includes two different approaches, namely, cryofreezing and carboxymethylcellulose. In cryofreezing, seafood items, such as salmon, tuna, shrimp, oysters, and tilapia, are kept in ultra-low liquid nitrogen for maintaining their quality. On the other hand, carboxymethylcellulose is used to curb the adulteration of seafood commodities. We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report. Request for a PDF sample of this report : https...
Read more

Biosimilar Market Size 2022-27: Trends, Share, Growth, Opportunity and Forecast

Image
According to the recent report by IMARC Group, entitled “ Biosimilar Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027 ”, the  global biosimilar market size was estimated to be US$ 13.0 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 60.8 Billion by 2027, exhibiting at a CAGR of 26.1% during 2022-2027. Biosimilars, also known as subsequent entry biologics (SEBs) or follow-on biologics, refer to FDA-approved biotherapeutic products which are similar to their reference biologics. Biosimilars can only be manufactured after the patent of the reference product expires. The demand for biosimilars has been increasing in recent years as they help in reducing the overall cost of the treatment for a variety of chronic diseases including cancers, autoimmune diseases, kidney failure, diabetes, CVDs, haematological disorders, infectious diseases, rheumatoid arthritis, growth hormone deficiency, etc. We are regularly track...
Read more